Market capitalization of AstraZeneca (AZN)

Market cap: A$360.56 Billion

As of October 2024 AstraZeneca has a market cap of A$360.56 Billion. This makes AstraZeneca the world's 43th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

End of year Market Cap

End of Day market cap according to different sources

On Oct 17th, 2024 the market cap of AstraZeneca was reported to be:

A$360.56 Billion

by Yahoo Finance

A$360.56 Billion

by CompaniesMarketCap

A$360.56 Billion

by Nasdaq

Market capitalization for similar companies or competitors

Name	Marketcap	Market cap differencediff.	Country
Bristol-Myers Squibb BMY	A$160.70 B	-55.43%	🇺🇸 USA
Pfizer PFE	A$247.21 B	-31.43%	🇺🇸 USA
Merck MRK	A$414.64 B	15.00%	🇺🇸 USA
GlaxoSmithKline GSK	A$118.43 B	-67.15%	🇬🇧 UK
Sanofi SNY	A$206.74 B	-42.66%	🇫🇷 France
Eli Lilly LLY	A$1.230 T	241.37%	🇺🇸 USA
Johnson & Johnson JNJ	A$590.11 B	63.67%	🇺🇸 USA
Abbott Laboratories ABT	A$305.72 B	-15.21%	🇺🇸 USA
Biogen BIIB	A$41.15 B	-88.59%	🇺🇸 USA
Novartis NVS	A$352.42 B	-2.26%	🇨🇭 Switzerland